OA02.07 Low Dose CT Lung Screening in First Responders
نویسندگان
چکیده
منابع مشابه
Low dose CT screening for lung cancer.
NOTICE: Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc., provide these Clinical Review Criteria for internal use by their members and health care providers. The Clinical Review Criteria only apply to Kaiser Foundation Health Plan of Washington and Kaiser Foundation Health Plan of Washington Options, Inc. Use of the Clinical Review Criter...
متن کاملLow-Dose CT for Lung Cancer Screening.
Effective 1/1/2015, New York State Medicaid will cover Low Dose CT for lung cancer screening, following United States Preventive Services Task Force guidelines (http://www.uspreventiveservicestaskforce.org/uspstf/uspslung.htm). The target population includes asymptomatic adults aged 55-80 who have a 30pack-year smoking history, and currently smoke or have quit smoking within the past 15 years. ...
متن کاملScreening for lung cancer with low-dose CT scans.
Lung cancer represents the leading cause of cancer-related mortality in the world. In the past, many attempts were made to detect the disease at an early stage and subsequently reduce its mortality. Chest X-ray was abandoned for this purpose. For several years low-dose computed tomography has been introduced as a potential tool for early screening in a high-risk population. As demonstrated in s...
متن کاملScreening for lung cancer using low dose CT scanning.
BACKGROUND Lung cancer is the most common cause of cancer related death in Ireland. The majority of lung cancers are inoperable at the time of diagnosis and consequently the overall 5 year survival is less than 10%. The objective of the ProActive Lung Cancer Detection (PALCAD) study was to evaluate whether low dose chest computed tomographic scanning (LDCCT) can detect early stage asymptomatic ...
متن کاملLung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST)
After long debate about the worth of screening for lung cancer, and even about the merits of doing a randomized trial to address the issue, initial results from the first large-scale randomized controlled trial ever to show a reduction in lung cancer mortality associated with screening were announced to the public last November 4. The story behind this historical first is informative, and the e...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thoracic Oncology
سال: 2019
ISSN: 1556-0864
DOI: 10.1016/j.jtho.2019.09.029